US doctors regularly prescribe real drugs as placebo treatments

Oct 24, 2008

Many rheumatologists and general internal medicine physicians in the US say they regularly prescribe "placebo treatments" including active drugs such as sedatives and antibiotics, but rarely admit they are doing so to their patients, according to a study on bmj.com today.

The use of placebo treatments in clinical practice has been widely criticised because it is claimed that the practice by its very nature is deceptive and therefore violates patients' autonomy. But advocates of placebo treatments argue that they could offer effective treatment for many chronic conditions without necessarily deceiving patients. Despite the controversy, to date there has been little data on doctors' attitudes towards and the use of placebo treatments in the US.

Dr Jon Tilburt and his colleagues from the National Institutes of Health as well as collaborators at Harvard and the University of Chicago examined the attitudes and behaviours to placebo treatments in a national sample of general internal medicine physicians and rheumatologists in the US.

The researchers sent a confidential survey to 1200 randomly selected practising general internal medicine physicians and rheumatologists (a group of doctors who commonly treat patients with debilitating chronic conditions that are notoriously difficult to manage medically).

The authors report that among the 679 physicians (57%) who responded to the survey half of them said they prescribed "placebo treatments" on a regular basis. Most physicians (62%) believed the practice to be ethically acceptable and were happy to recommend or prescribe placebo treatments.

The most commonly used placebo treatments prescribed in the past year were over the counter painkillers (41%) or vitamins (38%). Some of the physicians reported using antibiotics (13%) and sedatives (13%) as placebos, only 3% reported using sugar pills.

Interestingly, among those who prescribe placebo treatments, most doctors (68%) said they typically describe the placebo treatments to patients as "a potentially beneficial medicine or treatment not typically used for their condition", only rarely did they admit to explicitly describing them to patients as "placebos".

Although there was only a moderate response rate to the survey (57%), even if all the non-responders never gave placebos, placebo prescribing is still surprisingly common, say the authors.

The authors say that while the use of placebos has been controversial, the physicians in the study did not believe they were behaving unethically by either using placebos or not being upfront with their patients about doing so.

They point out that understanding the role of placebo treatments in contemporary medicine is complex. They conclude that prescribing harmless treatments like vitamins or over the counter painkillers to promote positive expectations without full disclosure of motivations might not raise alarm bells, but prescribing antibiotics and sedatives when there is no clear medical indication could have serious adverse consequences for both patients and public health.

Source: British Medical Journal

Explore further: More than a quarter of emergency contraceptives in Peru falsified or substandard

add to favorites email to friend print save as pdf

Related Stories

Botox to iron out Australian asthma wrinkles

Jun 28, 2011

It is more celebrity than respiratory, but botox could prove a breath of fresh air for asthmatics if an Australian trial of the toxin launched Tuesday is successful.

Many with low thyroid missed because labs may be wrong

May 13, 2011

Millions of Americans - mostly women - could find the key to more energy, easier weight control, sharper thinking, less depression, less infertility, lower blood pressure and lower incidence of heart disease. It all ...

New therapy found for rare lung disorder

Mar 16, 2011

Researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have found that the FDA-approved drug sirolimus, used primarily to prevent rejection in organ transplant patients, stabilized ...

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments : 0

More news stories

Treating depression in Parkinson's patients

A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's ...

Impact glass stores biodata for millions of years

(Phys.org) —Bits of plant life encapsulated in molten glass by asteroid and comet impacts millions of years ago give geologists information about climate and life forms on the ancient Earth. Scientists ...